Auronext Pharma Profile
Key Indicators
- Authorised Capital ₹ 255.00 Cr
- Paid Up Capital ₹ 124.98 Cr
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 36.50 Cr
- Revenue Growth 22.85%
- Profit Growth 49.22%
- Ebitda 29.61%
- Net Worth -1.47%
- Total Assets -0.04%
About Auronext Pharma
Auronext Pharma Private Limited (APPL) is Amalgamated company established on 02 Jul 2009 with its office registered at Rangareddy, Telangana, India and has been running since 15 Year, 9 Months with a paid up capital of 124.98 Cr. According to MCA records, 4 Directors and 2 Signatories are linked to this company as of 18 Jan 2025.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TG2009PTC109591
- Company No.
109591
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2009
- Date of AGM
19 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Auronext Pharma Private Limited
Explore comprehensive data for Auronext Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Auronext Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Yellapragada | CFO | 01-Jul-2021 | Current |
Venkata Racharla  | Company Secretary | 15-Apr-2019 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madan Mettu | Director | 31-Aug-2020 | Current |
| Sarath Penaka | Director | 20-Aug-2009 | Current |
| Sapna | Director | 23-May-2019 | Current |
| Jacob Joseph | Whole-Time Director | 01-Jul-2021 | Current |
Financial Performance of Auronext Pharma.
Auronext Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.85% increase. The company also saw a substantial improvement in profitability, with a 49.22% increase in profit. The company's net worth dipped by a decrease of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auronext Pharma?
In 2023, Auronext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pravesha Industries Private LimitedMadan Mettu is a mutual person
Eugia Pharma Specialities LimitedMadan Mettu is a mutual person
- Aurobindo Pharma Ltd
Madan Mettu and Sarath Penaka are mutual person
- Curateq Biologics Private Limited
Madan Mettu is a mutual person
- Eugia Steriles Private Limited
Madan Mettu is a mutual person
- Aurozest Private Limited
Madan Mettu is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹36.50 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 35.00 Cr
- Axis Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2016 | Yes Bank Limited | ₹35.00 Cr | Satisfied |
| 02 Feb 2010 | Axis Bank Limited | ₹1.50 Cr | Satisfied |
How Many Employees Work at Auronext Pharma?
Auronext Pharma has a workforce of 293 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auronext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auronext Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Auronext Pharma
Recent activity within the organization
- Annual General Meeting
Auronext Pharma Private Limited last Annual general meeting of members was held on 19 Jun 2023 as per latest MCA records.
- Balance Sheet
Auronext Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Ravi Kiran Yellapragada was appointed as a Cfo was appointed as a Cfo on 01 Jul 2021 & has been associated with this company since 3 years 9 months .
- Director Appointment
Jacob Joseph was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Jul 2021 & has been associated with this company since 3 years 9 months .
- Charges
A charge registered on 21 Jul 2016 via Charge ID 100058300 with Yes Bank Limited was fully satisfied on 08 Feb 2021.
- Director Appointment
Madan Mohan Reddy Mettu was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 4 years 7 months .
Recent News, Updates & Announcement
- FDA Finds Issues at Aurobindo Pharma Facility, Stock Drops.
FDA: Aurobindo Pharma's manufacturing facility has incomplete and misleading documents. They also found issues with quality control and training. Equipment is not cleaned properly. Aurobindo says they will fix it. FDA inspected from Sept 19-27 and issued warning letter for other facility. Aurobindo's stock went down..
Frequently asked questions
What is the Incorporation or founding date of Auronext Pharma Private Limited?
Auronext Pharma Private Limited was incorporated on 02 Jul 2009.
What is authorized share capital and paid-up capital of Auronext Pharma Private Limited?
The authorized share capital of Auronext Pharma Private Limited is ₹ 255.00 Cr and paid-up capital is ₹ 124.98 Cr.
Who are the current board members & directors of Auronext Pharma Private Limited?
Currently 6 directors are associated with Auronext Pharma Private Limited.
- Madan Mohan Reddy Mettu
- Sarath Chandra Reddy Penaka
- Sapna
- Ravi Kiran Yellapragada
- Venkata Radhakrishna Racharla
- Jacob Joseph
What is the registered address of Auronext Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Auronext Pharma Private Limited is Galaxy Floors 22-24 Plot No. 1 Survey 83/1 Knowledge City, Raidurg Panmak Tha India, Hyderabad, Telangana, 500032.
What is the corporate identification number (CIN) and company number of Auronext Pharma Private Limited?
The corporate identification number (CIN) of Auronext Pharma Private Limited is U74999TG2009PTC109591 and the company number is 109591 as per Ministry of Corporate Affairs (MCA).
What is the official website of Auronext Pharma Private Limited?
The Official website of Auronext Pharma Private Limited is https://www.aurobindo.com
What has been the recent revenue trend for Auronext Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Auronext Pharma Private Limited has risen by 22.85%.
How many employees does Auronext Pharma Private Limited currently have?
As Per 2023 financial reports, 293 employees are currently employed by Auronext Pharma Private Limited.
What change has been observed in the net worth of Auronext Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Auronext Pharma Private Limited has experienced an downturn of -1.47%.
When was the last Balance Sheet of Auronext Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Auronext Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Vinod AervaDirector
Vijay NatarajanDirectorGN
Govindarajan NarayananDirectorNJ
Naveen JainWholetime DirectorBS
Bodh SikriDirectorNK
Nityananda KambamDirectorAM
Anil MunjalDirectorVK
Venkateswararao KondreddyDirector
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India- Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India